FBIO
Fortress Biotech Inc.
$4.00
+$0.33(+8.99%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$109.20M
Volume
1.48M
52W Range
$1.33 - $3.97
Target Price
$11.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $2.6M | $33.0M | $17.2M | $3.5M | $1.7M | $1.1M | $5.7M | $72.9M | $59.7M | $55.1M | ||
| Total Revenue | $863.0K | $16.5M | $17.2M | $3.5M | $1.7M | $1.1M | $5.7M | $75.7M | $84.5M | $57.7M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-24.0K | $-790.0K | $3.7M | $6.1M | $10.5M | $14.6M | $41.6M | $30.8M | $22.9M | $20.9M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $2.6M | $32.2M | $13.6M | $-2.6M | $-8.8M | $31.0M | $36.7M | $45.0M | $61.6M | $36.8M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-51.4M | $-82.2M | $103.4M | $140.8M | $136.9M | $125.2M | $215.7M | $248.5M | $200.8M | $148.0M | ||
| Research & Development | $-18.4M | $40.7M | $52.5M | $87.4M | $81.3M | $64.1M | $128.8M | $134.9M | $106.1M | $56.9M | ||
| Research Expense | $-18.4M | $40.7M | $52.5M | $87.4M | $6.1M | $61.3M | $113.2M | $134.2M | $101.7M | $56.6M | ||
| Selling, General & Administrative | $-18.7M | $28.2M | $50.9M | $53.4M | $55.6M | $61.2M | $86.8M | $113.7M | $91.0M | $87.7M | ||
| Selling & Marketing Expenses | $-2.9M | $-5.8M | $-10.4M | $-11.6M | $-17.1M | $61.2M | $86.8M | -- | -- | -- | ||
| General & Administrative Expenses | $-18.7M | $28.2M | $50.9M | $53.4M | $55.6M | $-43.8M | $-2.1M | $113.7M | $91.0M | $87.7M | ||
| Salaries & Wages | $-14.3M | $-12.1M | $-13.4M | $-15.0M | $-13.2M | $-13.5M | $-19.5M | -- | $17.0M | $32.6M | ||
| Depreciation & Amortization | $-26.0K | $-400.0K | $-726.0K | $-1.4M | $-1.9M | $-2.3M | $-2.6M | $3.1M | $3.8M | $3.4M | ||
| Depreciation & Amortization | $-26.0K | $545.0K | $-726.0K | $-1.4M | $-1.9M | $-2.3M | $-2.6M | $3.1M | $3.8M | $3.4M | ||
| Amortization | $-314.0K | $-692.0K | $-3.1K | $-2.4M | $-4.5M | $-7.0M | $-3.9M | $2.1M | $3.8M | $3.4M | ||
| Other Operating Expenses | $51.4M | $82.2M | $-107.0M | $-6.1M | $-3.2M | $-3.2M | $-3.3M | $3.5M | $226.9M | $168.1M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-11.7M | $-118.9M | $-89.8M | $-143.4M | $-145.7M | $-138.8M | $-251.7M | $-206.4M | $-142.3M | $-110.4M | ||
| EBITDA | $-55.0M | $-72.2M | $-93.1M | $-126.3M | $-114.1M | $-87.8M | $-146.2M | $-193.7M | $-127.2M | $-97.7M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $-1.5M | $-3.7M | $-7.7K | $-10.3K | $-11.8M | $9.7M | $11.4M | $10.4M | $15.3M | $11.6M | ||
| Intinc | $-2.9M | $-75.8M | $819.0K | $1.1M | $2.6M | $-7.4M | $24.6M | $1.4M | $3.0M | $2.7M | ||
| Net Non-Operating Interest Income/Expense | $-2.9M | $-75.8M | $819.0K | $1.1M | $2.6M | $-7.4M | $24.6M | $12.2M | $3.0M | $2.7M | ||
| Gain on Sale of Securities | -- | -- | -- | $2.3M | $18.5M | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $438.0K | $1.0M | $8.5M | $-11.5M | $-41.5M | $-43.3M | $-62.7M | $2.3M | $-16.1M | $-2.3M | ||
| Other Special Charges | $-438.0K | $-1.0M | $-8.5M | $11.5M | $23.0M | $43.3M | $62.7M | $-8.6M | $16.1M | $2.3M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-200.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | $200.0K | $17.0M | $16.5M | -- | -- | -- | -- | -- | $-3.1M | $-3.7M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | $3.1M | $3.7M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-55.4M | $-75.0M | $-97.5M | $-130.8M | $-122.0M | $-93.1M | $-153.0M | $-203.0M | $-138.3M | $-109.0M | ||
| Pre-Tax Income | $-53.9M | $-71.3M | $-97.5M | $-130.8M | $-101.7M | $-102.8M | $-164.3M | $-213.5M | $-153.6M | $-120.5M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-66.7M | -- | $-1.5M | $-10.2M | $-12.4M | $136.0K | $473.0K | $449.0K | $521.0K | $312.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-9.6M | $-179.6M | $-66.9M | $-84.1M | $-40.0M | $-46.5M | $-64.7M | $-86.6M | $-60.6M | $-46.0M | ||
| Net Income (Continuing Operations) | $-9.6M | $-179.6M | $-66.9M | $-84.1M | $-40.0M | $-46.5M | $-64.7M | $-213.9M | $-154.2M | $-120.9M | ||
| Net Income (Discontinued Operations) | $-9.6M | $-179.6M | $-66.9M | $-84.1M | $-40.0M | $-46.5M | $-64.7M | $-86.6M | $-60.6M | $-46.0M | ||
| Net Income (Common Stockholders) | $-9.6M | $-179.6M | $-66.9M | $-84.1M | $-40.0M | $-46.5M | $-64.7M | $-94.6M | $-68.7M | $-55.9M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-115.6M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-51.4M | $-83.0M | $107.0M | $146.9M | $147.4M | $139.8M | $257.3M | $279.3M | $223.7M | $168.9M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $39.1M | $2.7M | $2.8M | $43.5M | $3.6M | $4.8M | $5.4M | $5.9M | $8.1M | $20.8M | ||
| Average Shares Outstanding (Diluted) | $7.7M | $1.2M | $2.8M | $43.5M | $3.6M | $4.8M | $5.4M | $5.9M | $8.1M | $20.8M | ||
| Shares Outstanding | $48.5M | $3.4M | $3.4M | $61.3M | $5.2M | $6.6M | $7.2M | $8.9M | $22.7M | $33.0M | ||
| Basic EPS | $-1.21 | $-22.2 | $-24.15 | $-5.21 | $-38.85 | -- | -- | $-14.55 | $-8.47 | $-2.69 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-24.15 | $-4.95 | $-38.85 | -- | -- | $-14.55 | $-8.47 | $-2.69 | ||
| Diluted EPS | $-1.24 | $-20.7 | $-24.15 | $-5.21 | $-38.85 | $-21.45 | $-30.3 | $-14.55 | $-8.47 | $-2.69 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-9.75 | $-11.85 | $-14.55 | $-8.47 | $-2.69 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | -- | -- | $-299.0K | $-2.3M | $-2.6M | $-6.5M | $-8.0M | $8.0M | $8.0M | $9.9M | ||
| Basic Discontinuous Operations | -- | -- | -- | $-0.26 | -- | -- | -- | -- | -- | -- | ||
| Commission Expenses | -- | $10.4M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Development Expense | -- | -- | -- | -- | $75.2M | $2.8M | $15.6M | $677.0K | $4.3M | $252.0K | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | -- | $-11.7 | $-18.45 | -- | -- | -- | ||
| Fees | -- | $7.1M | $104 | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | $18.5M | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | $-2.3M | $-13.5M | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | $-8.5M | $-9.7M | $-11.4M | $10.4M | -- | -- | ||
| Minority Interests | $5.5M | $16.2M | $33.0M | $57.8M | $61.7M | $56.5M | $100.1M | $127.3M | $93.5M | $74.9M | ||
| Net Income Discontinuous Operations | -- | -- | $-2.3M | $-11.1M | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | $1.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | $-810.0K | $2.3M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-18.7M | $28.2M | $50.9M | $53.4M | $55.6M | $-43.8M | $-2.1M | $113.7M | $91.0M | $87.7M | ||
| Other Impairment Of Capital Assets | -- | -- | $-250.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Other Taxes | -- | -- | -- | -- | $-400.0K | -- | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | -- | -- | $-299.0K | $-2.3M | $-2.6M | $-6.5M | $-8.0M | $8.0M | $8.0M | $9.9M | ||
| Preferred Stock Dividends | -- | -- | $-299.0K | $-2.3M | $-2.6M | $-6.5M | $-8.0M | $8.0M | $8.0M | $9.9M | ||
| Rent And Landing Fees | $-18.7M | $28.2M | $-1.2M | $-1.7M | $-2.1M | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | -- | -- | -- | $61.2M | $86.8M | -- | -- | -- | ||
| Othspecchg | -- | $-17.0M | $-16.5M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-200.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FBIO | $4.00 | +9.0% | 1.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |